Discontinued — last reported Q4 '25
Exxon Mobil Interest Paid decreased by 39.4% to $362.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 32.6%, from $537.00M to $362.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $223.00M | $517.00M | $506.00M | $234.00M | $525.00M | $547.00M | $309.00M | $584.00M | $598.00M | $313.00M | $684.00M | $537.00M | $339.00M | $597.00M | $362.00M |
| QoQ Change | — | +131.8% | -2.1% | -53.8% | +124.4% | +4.2% | -43.5% | +89.0% | +2.4% | -47.7% | +118.5% | -21.5% | -36.9% | +76.1% | -39.4% |
| YoY Change | — | — | — | +4.9% | +1.5% | +8.1% | +32.1% | +11.2% | +9.3% | +1.3% | +17.1% | -10.2% | +8.3% | -12.7% | -32.6% |